Structure Therapeutics Inc.
GPCR
$19.61
$0.241.24%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 786.50M | 836.88M | 883.52M | 915.29M | 927.12M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 12.80M | 12.74M | 7.69M | 8.37M | 10.50M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 799.30M | 849.62M | 891.21M | 923.65M | 937.62M |
|
|||||
Total Current Assets | 799.30M | 849.62M | 891.21M | 923.65M | 937.62M |
Net Property, Plant & Equipment | 10.94M | 10.83M | 7.01M | 7.74M | 7.58M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 6.20M | 6.10M | 5.11M | 1.82M | 1.83M |
Total Assets | 816.44M | 866.55M | 903.33M | 933.22M | 947.03M |
|
|||||
Total Accounts Payable | 8.99M | 8.71M | 8.02M | 8.45M | 2.21M |
Total Accrued Expenses | 27.38M | 25.31M | 26.30M | 23.14M | 18.78M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.66M | 2.47M | 1.70M | 1.71M | 1.63M |
Total Finance Division Other Current Liabilities | -- | -- | -- | 139.00K | 41.00K |
Total Other Current Liabilities | -- | -- | -- | 139.00K | 41.00K |
Total Current Liabilities | 39.03M | 36.49M | 36.02M | 33.43M | 22.66M |
|
|||||
Total Current Liabilities | 39.03M | 36.49M | 36.02M | 33.43M | 22.66M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 5.01M | 5.12M | 2.16M | 2.67M | 3.05M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 317.00K | 308.00K | 302.00K | 309.00K | 293.00K |
Total Liabilities | 44.36M | 41.91M | 38.49M | 36.42M | 26.00M |
|
|||||
Common Stock & APIC | 1.21B | 1.20B | 1.19B | 1.19B | 1.18B |
Retained Earnings | -437.59M | -375.93M | -329.10M | -292.62M | -258.64M |
Treasury Stock & Other | 362.00K | 815.00K | 914.00K | 2.84M | -487.00K |
Total Common Equity | 772.08M | 824.64M | 864.84M | 896.80M | 921.03M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 772.08M | 824.64M | 864.84M | 896.80M | 921.03M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 772.08M | 824.64M | 864.84M | 896.80M | 921.03M |
|